Oral OSA Drug Sulthiame Reduces AHI in Published Phase 2 Study
The once-daily oral carbonic anhydrase inhibitor met its primary endpoint, reducing AHI and improving nocturnal oxygenation in adults with moderate to severe OSA.
Read More
Author: Sleep Review Staff
Nanit Launches AI-Powered Sleep Score for Infants
The new feature uses camera-captured data and a science-backed framework to provide parents with a single daily sleep metric.
Read More
Re-Time Launches Smart Ring
The new wearable, developed by sleep researchers, tracks key biometrics to provide personalized sleep insights.
Read More
Study Links Insomnia to Disrupted Circadian Rhythm of Mental Activity
New research suggests individuals with insomnia fail to cognitively disengage at night due to a delayed mental activity peak, pointing to potential circadian-based treatments.
Read More
Insomnia, Depression Compound Dementia Risk, Study Finds
A study of nearly 2 million patient records reveals that the presence of both conditions in adults over 50 increases dementia risk by 72%.
Read More